Ketanov, 30 mg/ml 1 ml 10 pcs

Ketanov – means improving cerebral circulation, vasodilator, neuroprotective, anti-aggregative, anti-hypoxic.

It selectively increases cerebral blood flow and microcirculation, improves the supply of oxygen to the brain.

It has a neuroprotective effect, increases the tolerance of cerebral hypoxia by activating aerobic utilization of glucose and metabolism of adrenaline and serotonin in the brain tissue.

It improves the transport of oxygen to the tissues.

Reduces platelet aggregation and increased blood viscosity, increases the plasticity of red blood cells.

Indications

Pain syndrome of moderate and severe intensity of different genesis (including in the postoperative period, in cancer).

Active ingredient

Ketorolac

Composition

1 ampoule contains ketorolac tromethamine 30 mg,

sodium chloride 4.35 mg,
.

alcohol 10% w/v,

sterile water for injection 1 ml

How to take, the dosage

The solution for injection is administered by injection/m in a single dose of 10-30 mg (depending on the severity of the pain syndrome), then 10-30 mg every 4-6 hours.

The maximum duration of use of the solution for injection is 2 days.

The maximum daily dose of the drug (for any dosage form) is 90 mg.

In patients weighing less than 50 kg, persons over 65 years of age and patients with renal dysfunction the maximum daily dose is 60 mg.

Interaction

Parenteral administration of heparin increases the risk of bleeding.

Concomitant use of Ketorolac with other NSAIDs increases the risk of side effects.

In vitro Ketorolac decreases the binding of warfarin to plasma proteins.

.

Special Instructions

In hemorrhagic cerebral stroke parenteral use is allowed only after the acute phenomena have disappeared (usually after 5-7 days).

Prescribed by doctor

.

Contraindications

• gastric and duodenal ulcer in the acute phase;
• gastrointestinal bleeding;
• bronchial asthma;
• explicit cerebro-vascular disorders;
• moderate and severe renal dysfunction, risk of renal failure with hypovolemia and dehydration;
• blood clotting disorders in anamnesis;
• hemorrhagic diathesis;
• current use with other NSAIDs;
• high sensitivity to ketorolac and other NSAIDs.

.

Side effects

• stomatitis,
• nausea,
• constipation,
• dyspepsia,
• gastritis,
• erosive and ulcerative lesions of the gastrointestinal tract,
• dry mouth,

somnia,

and gastritis,

• dyspeptica.
• gastrointestinal erosive lesions,
• dry mouth,
• sleepiness,
• dizziness,
• nervousness,
• paresthesias,
• frequent urination,
• acute renal insufficiency,
• nephrotic syndrome,
• increased plasma creatinine and/or urea levels,
hypokalemia,
• hyponatremia,
• bradycardia,
• changes in BP,
• purulence,
• hematoma formation,
• nasal bleeding,
• longer clotting time,
• dyspnea,
• hives,
• thirst

Overdose

There are no clinical data on acute overdose of the drug.

In experimental studies after a single administration of 100 mg/kg body weight in animals there were such symptoms as decreased activity, diarrhea, difficulty in breathing, vomiting.

.

Similarities

Dolac, Ketorol, Ketonov, Ketorolac, Ketorolac Rompharm